These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24060587)

  • 1. The nesfatin 1 level in male patients with manic episode and alterations of nesfatin 1 level after antipsychotic and electroconvulsive treatment.
    Emul M; Karamustafalioglu N; Kalelioglu T; Genc A; Tasdemir A; Gungor FC; Incir S; Seven A
    J Affect Disord; 2013 Dec; 151(3):849-53. PubMed ID: 24060587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatment.
    Genc A; Kalelioglu T; Karamustafalioglu N; Tasdemir A; Gungor FC; Genc ES; Incir S; Ilnem C; Emul M
    Psychiatry Clin Neurosci; 2015 Jun; 69(6):344-50. PubMed ID: 25297388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma BDNFs level initially and post treatment in acute mania: comparison between ECT and atypical antipsychotic treatment and healthy controls.
    Karamustafalioglu N; Genc A; Kalelioglu T; Tasdemir A; Umut G; Incir S; Akkuş M; Emul M
    J Psychopharmacol; 2015 Aug; 29(8):898-902. PubMed ID: 25827643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial and post-treatment total oxidant-antioxidant status and oxidative stress index in male patients with manic episode.
    Kalelioglu T; Genc A; Karamustafalioglu N; Tasdemir A; Can Gungor F; Cansiz A; Incir S; Cem Ilnem M; Emul M
    Psychiatry Res; 2014 Aug; 218(1-2):249-51. PubMed ID: 24768245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode.
    Li H; Hong W; Zhang C; Wu Z; Wang Z; Yuan C; Li Z; Huang J; Lin Z; Fang Y
    J Affect Disord; 2015 Mar; 174():361-6. PubMed ID: 25545602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine.
    Kreys TJ; Fabian TJ; Saul MI; Haskett R; Coley KC
    J Psychiatr Pract; 2013 Jul; 19(4):288-95. PubMed ID: 23852103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Levels of Orexin-A, Nesfatin-1, Agouti-Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism.
    Tohma Y; Akturk M; Altinova A; Yassibas E; Cerit ET; Gulbahar O; Arslan M; Sanlier N; Toruner F
    Thyroid; 2015 Jul; 25(7):776-83. PubMed ID: 25915725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of serum nesfatin-1 and ghrelin levels with metabolic syndrome in patients with schizophrenia.
    Ünal K; Yüksel RN; Turhan T; Sezer S; Yaylaci ET
    Psychiatry Res; 2018 Mar; 261():45-49. PubMed ID: 29278806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of nesfatin-1 and fat mass in cystic fibrosis.
    Cohen RI; Ginsberg N; Tsang D; Wann LC; Ye X; Liu SF
    Respiration; 2013; 86(4):312-7. PubMed ID: 23306670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease.
    Başar O; Akbal E; Köklü S; Koçak E; Tuna Y; Ekiz F; Gültuna S; Yιlmaz FM; Aydoğan T
    Scand J Clin Lab Invest; 2012 Oct; 72(6):479-83. PubMed ID: 22950627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma nesfatin 1 level in patients with first attack psychosis.
    Sahpolat M; Ari M
    Bratisl Lek Listy; 2017; 118(2):77-79. PubMed ID: 28814086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroconvulsive therapy for manic state with mixed and psychotic features in a teenager with bipolar disorder and comorbid episodic obsessive-compulsive disorder: a case report.
    Rask O; Suneson K; Holmström E; Bäckström B; Johansson BA
    J Med Case Rep; 2017 Dec; 11(1):345. PubMed ID: 29228982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is There a Relationship between Obstructive Sleep Apnea Syndrome Severity and Nesfatin-1?
    Araz O; Yilmazel Ucar E; Dorman E; Bayraktutan Z; Yayla M; Yilmaz N; Acemoglu H; Halici Z; Akgun M
    Respiration; 2015; 90(2):105-10. PubMed ID: 26088934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children.
    Abaci A; Catli G; Anik A; Kume T; Bober E
    Pediatr Diabetes; 2013 May; 14(3):189-95. PubMed ID: 23346951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of Nesfatin-1 levels in patients with OSAS associated with metabolic syndrome.
    Aksu O; Aydın B; Doguç DK; Ilhan I; Ozturk O; Altuntas A; Demirkan H; Koroglu BK; Tamer MN
    J Endocrinol Invest; 2015 Apr; 38(4):463-9. PubMed ID: 25432328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of circulating nesfatin-1 in the underweight children with poor appetite.
    Kaba S; Karaman K; Kömüroğlu U; A Bala K; Demir N; Kocaman S; Doğan M; Ceylan N
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4703-6. PubMed ID: 26744860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma nesfatin-1 level in obese patients after acupuncture: a randomised controlled trial.
    Guo Y; Xing M; Sun W; Yuan X; Dai H; Ding H
    Acupunct Med; 2014 Aug; 32(4):313-7. PubMed ID: 24813558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial.
    McIntyre RS; Brecher M; Paulsson B; Huizar K; Mullen J
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):573-85. PubMed ID: 16139175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
    Bond DJ; Kauer-Sant'Anna M; Lam RW; Yatham LN
    J Affect Disord; 2010 Jul; 124(1-2):108-17. PubMed ID: 19914720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.